# About MOTS-c peptide Reviews: An Independent Literature Digest

> MOTS-c peptide Reviews is an independent editorial project summarizing the peer-reviewed research on MOTS-c. Not a clinic, not a vendor — editorial commentary on published science.

An independent editorial project that reads the MOTS-c literature straight — what the studies measured, in which species, and where the evidence stops.

## What this site is

MOTS-c Reviews is an independent editorial project that publishes summaries of the peer-reviewed research literature on the MOTS-c peptide. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The "reviews" in our name describes our method, not a verdict: we review the published record — the founding 2015 metabolic paper, the aged-mouse performance data, the human biomarker associations, the 2024 mechanism work — and present it in plain language with the citation attached. It does not mean we review or rate products, and it is not a collection of user testimonials.

## How we read the evidence

Three rules govern every page. Species are labeled: a result in mice is reported as a result in mice, and the milligram-per-kilogram doses throughout are rodent methodology, never human instructions. The human thread is kept separate and honest: the strongest human data are biomarker associations, which we never inflate into demonstrated outcomes. And the regulatory line is stated in the present tense and cited to FDA, including MOTS-c's place on the July 2026 PCAC evaluation agenda.

Where the evidence is precise, we are precise. Where it does not exist — a human half-life, a completed safety trial, a human dose — we say so directly rather than hedging around it.

## What the name means

The domain modifier is editorial framing, not a claim about services. MOTS-c Reviews occupies a position relative to the literature — a reader and summarizer of it — and nothing more. We offer no treatment, no consultation, no prescription, and no product. We have no physical clinic, no medical staff, and no commercial relationship with any seller of MOTS-c. The retro, HUD-styled presentation is a design choice for legibility and scanability; the substance is the cited science beneath it.

---

A pixel-clean readout of the MOTS-c record — the AMPK mechanism, the aged-mouse data, and the biomarker thread logged to source and tagged confirmed, every missing human datum flagged in plain HUD caution, with no clinic behind the screen and nothing here dispensed or sold.